35 related articles for article (PubMed ID: 2106742)
1. Explanation for loss of the HLA matching effect.
Starzl TE; Rao AS; Trucco M; Fontes P; Fung JJ; Demetris AJ
Transplant Proc; 1995 Feb; 27(1):57-60. PubMed ID: 7879102
[No Abstract] [Full Text] [Related]
2. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
3. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
4. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
5. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation.
Kaminski E; Hows J; Man S; Brookes P; Mackinnon S; Hughes T; Avakian O; Goldman JM; Batchelor JR
Transplantation; 1989 Oct; 48(4):608-13. PubMed ID: 2508280
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic bone marrow transplantation with non-T-cell-depleted marrow from two HLA-antigen-mismatched related donors.
Ogawa H; Ikegame K; Kawakami M; Taniguchi Y; Oka Y; Kawase I
Haematologica; 2004 Mar; 89(3):373-5. PubMed ID: 15020286
[TBL] [Abstract][Full Text] [Related]
7. Acute graft-versus-host disease and slow marrow recovery after transplantation of OKT8-positive T cell-depleted marrow from an HLA mismatched related donor. Kanazawa Bone Marrow Transplantation Team.
Shiobara S; Harada M; Ohtuka M; Mori T; Matsuda T; Nibu K
Transplant Proc; 1990 Feb; 22(1):257-9. PubMed ID: 2106742
[No Abstract] [Full Text] [Related]
8. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
Vossen J
Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
[TBL] [Abstract][Full Text] [Related]
10. Rationale for large scale bone marrow hemopoietic stem cell manipulation.
Menichella G; Pierelli L; Vittori M; Paoloni A; Foddai ML; Serafini R; Iacone A; Mango G
Haematologica; 1991 Mar; 76 Suppl 1():3-6. PubMed ID: 1677911
[TBL] [Abstract][Full Text] [Related]
11. HLA-identical marrow transplantation in the leukemias without T-cell depletion. The Seattle Marrow Transplant Team.
Storb R; Appelbaum F; Buckner CD; Clift R; Anasetti C; Beatty P; Bianco J; Doney K; Hansen J; Martin P
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():80-4. PubMed ID: 2117976
[No Abstract] [Full Text] [Related]
12. Selection of marrow donors for patients lacking an HLA-identical sibling.
Anasetti C; Beatty PG
Cancer Treat Res; 1990; 50():129-40. PubMed ID: 1976347
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
